Skip to content

Natasha Olsson

Global business development as key competence

With extensive knowledge from the pharmaceutical industry and having participated in successful launches of innovative products, Mårten Österlund is now Chairman for Neobiomics’ Board of Directors. In this interview, Mårten shares his extraordinary story. He was part of a dedicated team that led MEDAs expansion to become a multi-national company and now he is an advisor for start-ups. What can be learnt and why did he connect… Read More »Global business development as key competence

Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Stockholm, Sweden, 21 May, 2021 – Neobiomics AB and ExCEEd Orphan s.r.o. have entered an exclusive distribution agreement valid for 14 countries in Central and Eastern Europe (CEE). The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately.  Neobiomics is a Sweden-based company specialized in the area of neonatal and… Read More »Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Stockholm, Sweden, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB is a Sweden-based company… Read More »Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland